Clinical Trial Update: RewinD-LB - Clinical Study of Neflamapimod in Patients With Dementia With Lewy Bodies [Phase 2]

View source ↗

Summary

Phase 2 study of neflamapimod in dementia with Lewy bodies has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dementia with Lewy Bodies

Drugs mentioned

• Neflamapimod (neflamapimod)

Snippet

Sponsor: EIP Pharma Inc | Conditions: Dementia With Lewy Bodies | Phase 2 | Status: COMPLETED